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Abstract
For the purpose to clarify whether or not the cells of regional lymph nodes and spleen of
the tumor bearing individual develop the antitumor activity the author observed the proliferation
of JTC-11 cells in vitro by mixing with the lymph-node and spleen cells from the mice bearing
Ehrlich ascites tumor in solid form. After 24- to 48 -hour incubation the antitumor activity was
estimated from the number of proliferated JTC-11 cells. As the result, it has been found that
one week after implantation of tumor the regional lymph-node cells acquire the inhibitory activity
against the proliferation of JTC-11 cells. The spleeen cells also show a marked inhibitory effect
on the turner cell proliferation but two weeks after implantation these inhibitory activities of the
cells both from lymph node and spleen are largely retarded three to four weeks when the host is
emanciated by the growing tumors. Discussions are made on the inhibitory mechanisms from the
viewpoint of immune reaction and on the transplantability of tumor cells without any rejection.
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In spontaneous cancer, especially in human cancer, there is yet no defini-
tive evidence that the host would present immunological reaction against the
tumor recognizing it as not-self. In the past several decades many attempts have
been made to detect immuno-antibodies in the serum of cancer patients but no
convincing evidence seems to be presented up to date. Nonetheless, at the pre-
sent stage in the light of studies on autoimmune diseases and homotransplan-
tation immunity this problem appears to be understood somewhat on the concept
of tissue immunity or delayed type of allergy-like immunity. Actually, KLEIN\
in his autoimmune experiments with mice by inducing methylcholanthrene carci-
noma in animals, has reported that for the antitumor activity of the tumor
bearing mice the lymphoid cells are responsible. T AKEDA2 likewise has found
the antitumor activity in lymphoid cells from F 1 strain mice sensitized with MH
134 tumor cells (originating from CaH strain mouse) killed by irradiation with
x-ray. As has been reported repeatedly, even in human cancer the tumors hav-
ing intense infiltration of round cells in the surrounding interstitium proves to be
good in prognosis. By means of tissue culture method HANAOKAu,4 and ROSENAU"
have observed mutual cell damaging reaction between target cells and lymphoid
cells from the host receiving homotransplantation in which the grafted tissue is
rejected. These results seem to suggest the possibility that the cellular immune
reaction between the tumor cells and the host lymphocytes can be seen directly
in vitro by applying the tissue culture method. In view of this, the author
carried out a series of experiments by means of tisstl,e culture technique in order
to see the reaction of the lymphoid cells of cancer bearing mice to the tumor
cells. In this paper it is reported that the antitumor activity of lymphoid cells
can be also evidenced in vitro experiment.
MATERIALS AND METHODS
Cb strain male mice of 4 weeks old were obtained from The Mouse Colony
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of Okayama University. The animals were fed on solid feed, MF of Oriental
Yeast Co. with fresh vegetables and after growing up to about 20 g in body
weight, they were used for experiment. These mice received the transplantation
of tumors, Ehrlich ascites tumor cells or lTC-II cells", subcutaneously. Each
5 X 106 cells of Ehrlich ascites tumor were implanted in between the shoulder
bone and scapula on both sides. lTC-II cells in culture grown in the medium
composed of 80 % YLE solution and 20 % bovine serum8 were also transplanted
subcutaneously between the shoulder bone and scapula on both sides as in the
case of Ehrlich ascites tumor cells. Each animal received 3 injections of the cell
at the intervals of one week, 2,000 cells at one time. Both of Ehrlich tumor
cells and JTC-II cells were donated by the courtesy of Cancer Institute of
Okayama University Medical School. The animals receiving Ehrlich ascites cells'
transplantation were sacrificed one, two, three, and four weeks after the trans-
plantation and these treated with JTC-ll cells one week after the last injection.
From these animals lymph nodes of the axilla and cervical regions and the
spleen were obtained and from each organ the tissue extract was prepared sepa-
rately i: e. each of these samples was cut into small pieces with ophthalmic
scissors in cold Hanks solution, and centrifuged at 1,000 r. p. m. for 10 minutes.
The sediment was washed with cold Hanks solution three times by repeated
centrifugation at 1,000 r. p. m. for 10 minutes each. With this sediment cell
suspension was prepared. This lymphoid cell suspension was mixed with the
substrain of Ehrlich tumor cells, JCT-ll, and cultured in the YLE medium
containing 20 % of bovine serum, i. e. 1 X 104 lTC-ll cells were mixed with
2 X 105 --1 X 106 cells of lymphoid cells in 1.5 ml of the medium in a short culture
vessel. Cell counts were taken on the tumor cells surviving 24- and 48-hour
cultures at 37°C. As the control groups for each of the above test groups mixed
cultures were carried out with lTC-II cells and lymph-node cells or spleen cells
obtained from untreated mice, and the cell number of JTC-ll was counted at
the same intervals as in the case of test groups. Prior to the counting of cells,
the cells growing on the wall of culture vessel were gently scraped off with
rubber cleaner. For counting cell number citric acid treatment, a modified
method by KATSUTA after SANFORD'S principle, was employed, i. e. the number of
stained nuclei was computed on the calculating plate of BURGER-TuRK, avoiding
inclusion of the number of erythrocytes. For the determination of viability of
the cells the "unstained cell count method,,7 of SCHREK was employed, i. e. after
supravital staining with 1 % Eosin Y solution, the number of the stained cells
was subtracted from the whole cell number counted previously. The rate at
which cells are stained was 30 % at maximum and 1296 at minimum, showing
a variety of percentage. For the present experiment those that showed over
80 % viable cells were used. As for counting cells in culture the cell number
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was determined by the average count from 3-4 vessels.
RESULTS
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In the lTC-II cells incubated with the regional lymph-node cells from the
animal having the implanted Ehrlich tumor cells the number of lTC-II cells
showed a marked suppressed proliferation already one week after sensitization,
most markedly after two weeks, and three to four weeks after the implantation
when the death from tumors approached, the proliferation rate recovered to
some extent (Fig. 1).
In the lTC-ll cells incubated with the regional lymph-node cells obtained
two weeks after the tumor inoculation the lTC·II proliferation was markedly
inhibited, and the suppressing effect became more marked with the increase in
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Fig. 1 Inhibition of the JTC-ll cell growth
by the regional lymph·node cells from the ani-
mals implanted with Ehrlich cancer cells. 0;
control, 1; 1 week after implantation, 2 ;
2 weeks after implantation, 3; 3 weeks after
implantation, 4; 4 weeks after implantation,
Method; see text. lymph·node cells; 2x106
Fig. 2 Inhibition of the JTC·ll cell growth
by the regional lymph·node cells from the ani-
mals implanted Ehrlich cancer cells obtained two
weeks after the tumor inoculation. A; incuba-
ted with 5 X 1()5 lymph-node cells, B; incubated
with 1 X 106 lymph·node cells, C; control,
Method; see text.
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the number of lymphoid cells and even by 48-hour incubation the cells did not
proliferate exceeding the original level (Fig. 2).
As in the case of lymph-node cells the spleen cells showed also a fairly
marked inhibitory effect on the proliferation of JTC-ll. That is, the spleen
cells from the animal one week after the tumor inoculation showed hardly any
inhibition on the tumor cell growth but those affected with the spleen cells taken
two weeks after the tumor inoculation showed a marked inhibitory effect as
in the case of lymph-node cells from the tumor bearing animals. Such an
inhibitory effect of the spleen cells was also diminished 3 to 4 weeks after the
tumor inoculation at the time when the death from tumors approached (Fig. 3).
The inhibitory effect of spleen cells on the proliferation of JTC-II cells was
stronger than that of lymph-node cells at the corresponding stage.
In the case where the regional lymph-node cells or spleen cells from the
animals transplanted with lTC-II cells there was only a slight inhibitory effect on
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Fig. 3 Inhibition of the JTC-ll cell growth
of the spleen cells from the animals implanted
Ehrlich cancer cells. 0; control, 1; 1 week
after implantation, 2; 2 weeks after implan-
tation, 3; 3 weeks after implantation, 4; 4
weeks after implantation, Method; see text.
Fig, 4 The growth of JTC-ll cells incu-
bated with the lymphoid cells from the animals
receiving the transplantations of 3 times with
the intervals of one week. SP; incubated with
spleen cells, LY; incubated with lymph-node
cells, C; control (JTC·ll cells alone), Method;
see text.
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the lTC-11 cells. After 24-hour inoculation the cell proliferation seemed to be
inhibited to some degree but they increased markedly after 48 hours.
DISCUSSION
Through this experiment it has been clarified that regional lymph-node
cells and spleen cells of the mice receiving the implantation of Ehrlich ascites
tumor cells acquire an inhibitory activity to the proliferation of the tumor cells.
This antitumor activity increases with the growth of the tumor, reaching maxi-
mum after a certain period of time and then reduced with emanciation of the
animals.
Ehrlich cancer cells originally developed in hybrid mice and successively
maintained for several decades have proven that they grow in almost all
strains of mice when implanted. Generally, normal mouse tissue cells trans-
planted to the other strain of mouse is rejected after a certain period of time by
immune reaction. Here arises a problem why the tumor cells are not rejected
even at the stage where the host cells have acquired a marked antitumor activi-
ty.
The first problem to be solved is whether or not the antitumor activity
presented by the regional lymph-node cells or spleen cells is due to immune
reaction. Concerning the facts suggesting that lymphocyte is responsible for
tissue immunity many observations have been reported; HARRIS and HARRIS9,
and HARRI:; et al. 1O have demonstrated a rapid appearance of agglutinins in the
rabbit transplanted with cells of regional lymph nodes removed from another
rabbit previously sensitized by injection of dysentery or typhus organisms into
its foot pad. POTTER et al. (1938)1J succeeded in transfer of immunity to mouse
transplantable leukemia as target cells, by passive transfer of the spleen cells
from sensitized mice. MITCHISON12 also has succeeded in passive transfer with
homologous tumor transplantation. BILLINGHAM et al.13 in their study on homo-
logous skin graft transfer, having found that the transplanted skin graft is
readily rejected in the mice previously receiving transfer of cells from regional
lymph nodes.
Concerning in vitro studies, ROSENAU et al.b have found that such lymph-
node cells induce lysis of L cells in the absence of complement, and HANAOKA
et al.3.4 have observed an inhibition of proliferation of SCL leukemic cells in
vitro. KOPROWSKI14 injected guinea-pig bone marrow along with adjuvant into
rat and during tissue culture of sensitized lymph·node cells from the rat, he
made brain tissue come in contact with the cells in culture and observed that
the lymph-node cells reacted specifically with glia cells, bringing about a contac-
tual agglutination phenomenon. He also observed that non-treated lymph-node
5
Hara: Cellular antibody in mice bearing Ehrlich cancer. I.
Produced by The Berkeley Electronic Press, 1965
96 S. HARA
cells coming in contact with sensitized serum in vitro elicited a similar phenome-
non. WILSON1li observed that the lymphoid cells from the mice or rat that received
skin homograft transfer aggregated in an orderly manner onto target cells,
kidney cells in vitro, and on comparing the number of target cells with that of
non-sensitized kidney cells under similar conditions, he found a decrease in the
number of target cells in the former. In this instance, it was observed that the
greater the number of sensitized lymphoid cells, the more marked was the
decrease in the number of kidney cells. Similar phenomena have been observed
in the present experiments.
The stage where the antitumor activity reaches the maximum, also coinci-
des with that of maximal immune activity. In immunological study of Ehrlich
cancer in vivo NUMATA16 proved that immuno-antibody reaches its peak about
two weeks after subcutaneous transfer and one week after intraperitoneal im-
plantation. Concerning the delay in the appearance of antitumor activity of
spleen cells, the observations of MEDAWAR17 may be helpful for the analysis. By
unilateral transplantation of skin graft on rabbit ear, he observed the regional
lymph nodes and those on the opposite side which showed some delay in response.
By injecting dyes into the ears, he observed the dye does not reach directly to
the lymph nodes on the opposite side but indirectly through circulating blood.
This explains the delayed immune response of the opposite side lymph node.
The delayed antitumor activity of the spleen seen in the present experiment may
be well explained by the delayed intake of antigen by spleen.
Thus it is clear that the antitumor activity of lymph node and spleen is
solely due to the immune reaction. For the question why the tumor cells are not
rejected as in the case of normal tissue cells, it may be considered that the
immune reaction may be too weak to reject the transplanted tumor. Generally,
the antibody or tissue immunity seems to appear marked against the somatic
protein, which is produced by the differentiated cells. Undifferentiated tumor
cell does not develop somatic proteins and may be weak in antibody formation,
and this is the problem to be settled in future.
SUMMARY
For the purpose to clarify whether or not the cells of regional lymph nodes
and spleen of the tumor bearing individual develop the antitumor activity the
author observed the proliferation of JTC-II cells in vitro by mixing with the
lymph-node and spleen cells from the mice bearing Ehrlich ascites tumor in solid
form. After 24 - to 48 - hour incubation the antitumor activity was estimated
from the number of proliferated JTC-ll cells. As the result, it has been found
that one week after implantation of tumor the regional lymph-node cells acquire
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the inhibitory activity against the proliferation of JTC-II cells. The spleeen cells
also show a marked inhibitory effect on the turner cell proliferation but two
weeks after implantation these inhibitory activities of the cells both from lymph
node and spleen are largely retarded three to four weeks when the host is
emanciated by the growing tumors.
Discussions are made on the inhibitory mechanisms from the viewpoint
of immune reaction and on the transplantability of tumor cells without any
rejection.
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